Feldt, Robert

BACKGROUND The purpose of this study was to estimate survival and quality of outcome and assess factors associated with outcome for patients out 5 to 15 years from their Fontan operation. METHODS AND RESULTS We studied 352 patients who had the Fontan operation prior to 1985. The overall 1-, 5-, and 10-year survival was 77%, 70%, and 60%, respectively. The following factors were significantly associated with lower survival: univentricular heart or complex congenital anomalies other than tricuspid atresia, early calendar year of operation, heterotaxia syndromes, early age at operation, increased pulmonary artery pressure, atrioventricular valve dysfunction, and higher (worse) New York Heart Association class. Reoperations were necessary for 103 of the 352 patients. At least 20% of the survivors have or have had cardiac arrhythmias requiring antiarrhythmic medication or mechanical pacemaker insertion. Between 7% and 10% of the patients have had or had protein-losing enteropathy/hypoproteinemia. At 5 years postoperatively, 122 patients (34.7%) were alive with a better New York Heart Association functional classification than preoperatively. Fifty-eight patients (16.5%) were alive and in the same functional classification, but 126 (35.8%) died within the first 5 years or were in a worse functional classification. Thirty-nine patients were doing excellently and 29 patients poorly 5 years after the operation. Of the surviving patients, 43% can do as much exercise as their peers, whereas 3% are incapable of exercise. CONCLUSIONS To assure good functional long-term outcome in addition to survival, clinicians must exclude from selection for Fontan operation patients known to be at high risk for death or poor outcome.

Atrial septal defect (ASD) of the fossa ovalis type was found in 16 members of one family and confirmed in 15 members at autopsy or surgery or by cardiac catheterization. Sinus rhythm was present in 12 affected members, 11 of whom had electrocardiographic evidence of prolonged atrioventricular (A-V) conduction. Five other family members without ASD also had prolonged A-V conduction. The pedigree chart suggests that the syndrome ASD with prolonged A-V conduction is the manifestation of a single mutant autosomal gene with dominant effect, a high degree of penetrance, and some variation in expressivity. Earlier reports of familial ASD showing the autosomal-dominant pattern of inheritance reveal a similar frequency of prolonged A-V conduction among affected persons. The great majority of cases of ASD are sporadic, with little likelihood of recurrence in subsequent sibs or children. We suggest, however, that when ASD of the fossa ovalis type is accompanied by prolonged A-V conduction, the genetic prognosis may be drastically changed to a risk of almost 50% that the condition will recur in subsequent sibs or children of affected persons.